DK1992351T3 - Lactobacillus johnsonii for the prevention of post-surgical infection - Google Patents

Lactobacillus johnsonii for the prevention of post-surgical infection Download PDF

Info

Publication number
DK1992351T3
DK1992351T3 DK07108492.5T DK07108492T DK1992351T3 DK 1992351 T3 DK1992351 T3 DK 1992351T3 DK 07108492 T DK07108492 T DK 07108492T DK 1992351 T3 DK1992351 T3 DK 1992351T3
Authority
DK
Denmark
Prior art keywords
composition
approx
nutritional composition
probiotics
protein
Prior art date
Application number
DK07108492.5T
Other languages
Danish (da)
English (en)
Inventor
Eduardo Schiffrin
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of DK1992351T3 publication Critical patent/DK1992351T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07108492.5T 2007-05-18 2007-05-18 Lactobacillus johnsonii for the prevention of post-surgical infection DK1992351T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07108492.5A EP1992351B1 (en) 2007-05-18 2007-05-18 Lactobacillus johnsonii for prevention of postsurgical infection

Publications (1)

Publication Number Publication Date
DK1992351T3 true DK1992351T3 (en) 2016-06-06

Family

ID=38476047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07108492.5T DK1992351T3 (en) 2007-05-18 2007-05-18 Lactobacillus johnsonii for the prevention of post-surgical infection

Country Status (15)

Country Link
US (2) US8529887B2 (cg-RX-API-DMAC10.html)
EP (2) EP1992351B1 (cg-RX-API-DMAC10.html)
JP (2) JP5497634B2 (cg-RX-API-DMAC10.html)
CN (2) CN103623010A (cg-RX-API-DMAC10.html)
AU (1) AU2008253040B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0811180A2 (cg-RX-API-DMAC10.html)
CA (1) CA2686976C (cg-RX-API-DMAC10.html)
CL (1) CL2008001446A1 (cg-RX-API-DMAC10.html)
DK (1) DK1992351T3 (cg-RX-API-DMAC10.html)
ES (1) ES2578261T3 (cg-RX-API-DMAC10.html)
MX (1) MX2009012255A (cg-RX-API-DMAC10.html)
RU (1) RU2470652C2 (cg-RX-API-DMAC10.html)
TW (1) TW200902040A (cg-RX-API-DMAC10.html)
WO (1) WO2008141989A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200909002B (cg-RX-API-DMAC10.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
US8825503B2 (en) * 2008-05-15 2014-09-02 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
US9474773B2 (en) 2009-02-18 2016-10-25 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
WO2010096564A2 (en) * 2009-02-19 2010-08-26 Probiohealth Llc Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
ES2503553T3 (es) 2009-04-03 2014-10-07 Metamodix, Inc. Prótesis gastrointestinales modulares
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
DK2459203T3 (en) 2009-07-30 2019-02-18 Dupont Nutrition Biosci Aps Lactic Acid Bacteria and Bifidobacteria for the Treatment of Endotoxemia
PH12013501773A1 (en) * 2011-03-31 2013-10-14 Nestec Sa Nutritional compositions for increasing arginine levels and methods of using same
DK2693885T3 (en) 2011-04-08 2018-05-22 Chr Hansen As Synergistic antimicrobial effect
CN103648511B (zh) * 2011-06-08 2018-12-07 诺沃奇梅兹有限公司 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途
CN102835657B (zh) * 2011-06-20 2014-08-20 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
IN2014DN07752A (cg-RX-API-DMAC10.html) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
EP2830599B1 (en) 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
AR090631A1 (es) * 2012-04-09 2014-11-26 Chr Hansen As Bioproteccion que usa cepas lactobacillus rhamnosus
UA115331C2 (uk) 2012-04-09 2017-10-25 Кр. Хансен А/С Біозахист з використанням штамів lactobacillus paracasei
WO2014113483A1 (en) * 2013-01-15 2014-07-24 Metamodix, Inc. System and method for affecting intestinal microbial flora
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
RU2565444C2 (ru) * 2013-11-28 2015-10-20 Федеральное государственное бюджетное учреждение науки Институт клеточного и внутриклеточного симбиоза Уральского отделения Российской академии наук Способ профилактики инфекционно-воспалительных осложнений у женщин с субмукозной миомой матки после гистерорезектоскопии
KR101445243B1 (ko) * 2014-03-28 2014-09-29 서울대학교산학협력단 장내 세균의 군집과 기능의 변화를 이용한 대사성 및 염증성 질환의 조기진단
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
US10751209B2 (en) 2016-05-19 2020-08-25 Metamodix, Inc. Pyloric anchor retrieval tools and methods
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
US11566238B2 (en) 2016-12-15 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
TWI784194B (zh) * 2019-09-04 2022-11-21 台達電子工業股份有限公司 抑制具萬古黴素抗藥性腸球菌之益生菌組合與其用途
CN112438995A (zh) 2019-09-04 2021-03-05 台达电子工业股份有限公司 抑制具万古霉素抗药性肠球菌的益生菌及其组合与其用途
US20220193156A1 (en) * 2020-12-23 2022-06-23 Thi Tuyet Mai Ta Preoperative compositions and methods of preparation thereof
US12377123B2 (en) * 2020-12-23 2025-08-05 Preoperative Nutrition Preoperative compositions and methods of preparation thereof
CN113559131A (zh) * 2021-07-23 2021-10-29 科为博(江苏)生物科技研究院有限公司 一种用于改善肠胃的益生菌粉

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
DE29724815U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
DK1003532T4 (da) 1997-07-05 2009-03-02 Nestle Sa Lactobacilli til fremme af tarmcellers mineralabsorption
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
ATE348626T1 (de) * 2000-03-24 2007-01-15 Nestle Sa Milchsäurebakterium zur prävention der bauchfellentzündung
US7794744B2 (en) * 2000-04-18 2010-09-14 Nestec S.A. Nutritional modules
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
SI1565547T2 (sl) * 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
KR20060109452A (ko) * 2003-10-02 2006-10-20 더 바이오 밸런스 코포레이션 건조 바이오치료 조성물, 용도, 그 투여 장치 및 투여 방법
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006046871A2 (en) * 2004-10-29 2006-05-04 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
RU2293568C1 (ru) * 2006-01-10 2007-02-20 Федеральное государственное учреждение Российский центр функциональной хирургической гастроэнтерологии Федерального агентства по здравоохранению и социальному развитию (ФГУ "РЦФХГ Росздрава") Способ периоперационной коррекции дисбиоза толстой кишки у больных колоректальным раком
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection

Also Published As

Publication number Publication date
CL2008001446A1 (es) 2009-10-02
CN103623010A (zh) 2014-03-12
JP2013216658A (ja) 2013-10-24
ES2578261T3 (es) 2016-07-22
ZA200909002B (en) 2011-02-23
TW200902040A (en) 2009-01-16
EP2146729A1 (en) 2010-01-27
MX2009012255A (es) 2009-11-25
US20100135971A1 (en) 2010-06-03
US8529887B2 (en) 2013-09-10
EP1992351A1 (en) 2008-11-19
CA2686976C (en) 2015-02-17
BRPI0811180A2 (pt) 2014-10-21
US9616094B2 (en) 2017-04-11
CN101678054A (zh) 2010-03-24
RU2470652C2 (ru) 2012-12-27
US20130344044A1 (en) 2013-12-26
JP2010527343A (ja) 2010-08-12
AU2008253040B2 (en) 2014-06-12
WO2008141989A1 (en) 2008-11-27
AU2008253040A1 (en) 2008-11-27
EP1992351B1 (en) 2016-05-11
CA2686976A1 (en) 2008-11-27
JP5497634B2 (ja) 2014-05-21
RU2009147036A (ru) 2011-06-27
JP6285108B2 (ja) 2018-02-28

Similar Documents

Publication Publication Date Title
CA2686976C (en) Probiotics in a pre- and/or post-surgical environment
ES2381232T3 (es) Procedimiento para el tratamiento o la prevención de la inflamación sistémica
RU2567660C2 (ru) Bifidobacterium longum ATCC BAA-999 (BL999) И КОНТРОЛИРОВАНИЕ ВЕСА
CN1239096C (zh) 营养组合物
JP6027491B2 (ja) 腎臓機能を増大させるための組成物および方法
EP1638416B1 (en) Use of a nutritional formula for optimal gut barrier function
BRPI0814934B1 (pt) USO DE Lactobacillus rhamnosus CGMCC 1.3724 NO CONTROLE DE PESO
PT2315595E (pt) Probióticos para aumentar a secreção de iga em lactentes nascidos por cesariana
CN102006788A (zh) 合益素混合物
TW201729693A (zh) 含有膳食性丁酸鹽之營養組成物和彼之用途
HK1250608A1 (zh) 包含乳铁蛋白的营养组合物在支持抵抗疾病和状况中的用途
NZ550501A (en) Use of a fermentation product of propionic acid bacterium for treating inflammatory bowel diseases
US9826766B2 (en) Use of polysaccharides for the intestinal well-being of nursing infants and/or infants
WO2022091075A1 (en) Combination compositions of probiotics with fermented wheat germ extract and uses thereof
KR20070122480A (ko) 조제유-수유 유아에서의 전신성 염증의 치료, 예방 또는감소를 위한 락토바실루스 람노수스 ｇｇ의 용도
Singh et al. Probiotics, prebiotics, and synbiotics: a potential source for a healthy gut
CN116583187A (zh) 用于促进幼儿中加速的丁酸盐生产的组合物
HK1191812A (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions